Efficacy and safety of anti‐PD‐1/PD‐L1 in combination with chemotherapy or not as first‐line treatment for advanced non‐small cell lung cancer: A systematic review and network meta‐analysis

BACKGROUND: The aim of this network meta‐analysis (NMA) was to evaluate the efficacy and safety of PD‐1/PD‐L1 inhibitors, alone or in combination with chemotherapy, as first‐line treatment for wild‐type advanced non‐small cell lung cancer. METHODS: We systematically searched databases, Clinical Tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liming, Yang, Yifan, Yu, Jiangyong, Zhang, Shuai, Li, Xu, Wu, Xiaonan, Nie, Xin, Liu, Wenbo, Zhang, Ping, Li, Yi, Li, Ailing, Ai, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807232/
https://www.ncbi.nlm.nih.gov/pubmed/34907661
http://dx.doi.org/10.1111/1759-7714.14244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807232/
https://www.ncbi.nlm.nih.gov/pubmed/34907661
http://dx.doi.org/10.1111/1759-7714.14244

Ejemplares similares